Publisher's Synopsis
This treatise examines the value of neoadjuvant chemotherapy for survival or bladder preservation. Using a multidisciplinary approach, it describes the results of clinical trials involving 35 patients and offers conclusions that can be compared with other studies and may reveal alternative methods to chemotherapy. Specifically covered are criteria for neoadjuvant chemotherapy eligibility, the extent of staging and restaging procedures, uniform definitions for the assessment of response, and the numerous types and extent of locoregional therapy following chemotherapy.
